Navid Koleini

1.5k total citations · 1 hit paper
30 papers, 1.0k citations indexed

About

Navid Koleini is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Navid Koleini has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Navid Koleini's work include Cardiovascular Function and Risk Factors (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Navid Koleini is often cited by papers focused on Cardiovascular Function and Risk Factors (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Navid Koleini collaborates with scholars based in Canada, United States and Iran. Navid Koleini's co-authors include Elissavet Kardami, Hossein Ardehali, Robert R. Fandrich, Barbara E. Nickel, Justin Geier, Jason Shapiro, Andrea L. Edel, Amir Ravandi, Soroor Arman and David A. Kass and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Navid Koleini

29 papers receiving 1.0k citations

Hit Papers

Myocardial Metabolomics of Human Heart Failure With Prese... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Navid Koleini Canada 13 397 373 151 132 125 30 1.0k
Paul C. Armstrong United Kingdom 23 543 1.4× 234 0.6× 174 1.2× 149 1.1× 88 0.7× 50 1.4k
Lucia Stefanini Italy 23 340 0.9× 379 1.0× 88 0.6× 145 1.1× 54 0.4× 47 1.5k
Yujun Xu China 22 198 0.5× 445 1.2× 214 1.4× 114 0.9× 165 1.3× 64 1.3k
Marina Bayeva United States 16 664 1.7× 830 2.2× 292 1.9× 257 1.9× 174 1.4× 18 1.8k
Can Chen China 21 147 0.4× 552 1.5× 172 1.1× 149 1.1× 276 2.2× 90 1.3k
Chunpeng Zou China 14 211 0.5× 310 0.8× 67 0.4× 100 0.8× 75 0.6× 35 799
Konrad Teodor Sawicki United States 13 227 0.6× 439 1.2× 111 0.7× 151 1.1× 110 0.9× 24 957
Ying Ye China 20 170 0.4× 474 1.3× 256 1.7× 149 1.1× 281 2.2× 56 1.2k

Countries citing papers authored by Navid Koleini

Since Specialization
Citations

This map shows the geographic impact of Navid Koleini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navid Koleini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navid Koleini more than expected).

Fields of papers citing papers by Navid Koleini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Navid Koleini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navid Koleini. The network helps show where Navid Koleini may publish in the future.

Co-authorship network of co-authors of Navid Koleini

This figure shows the co-authorship network connecting the top 25 collaborators of Navid Koleini. A scholar is included among the top collaborators of Navid Koleini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navid Koleini. Navid Koleini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koleini, Navid, Mohammad Keykhaei, Ting Liu, et al.. (2025). ATP-Citrate Lyase Supports Cardiac Function and NAD+/NADH Balance and Is Depressed in Human Failing Myocardium. JACC Basic to Translational Science. 10(7). 101301–101301.
2.
Mahmoodzadeh, Amir, Jason Shapiro, Mingyang Liu, et al.. (2025). Protein O-GlcNAcylation and hexokinase mitochondrial dissociation drive heart failure with preserved ejection fraction. Cell Metabolism. 37(7). 1584–1600.e10. 3 indexed citations
3.
Arvanitis, Marios, Sean Murphy, Navid Koleini, et al.. (2024). A transcriptional enhancer regulates cardiac maturation. Nature Cardiovascular Research. 3(6). 666–684. 3 indexed citations
4.
Jani, Vivek, Navid Koleini, Thomas E. Sharp, et al.. (2024). Cardiomyocyte myofilament function in common animal models of heart failure with preserved ejection fraction. Journal of Molecular and Cellular Cardiology. 197. 34–39. 2 indexed citations
5.
Koleini, Navid, Liang Zhao, Mohammad Keykhaei, et al.. (2024). Landscape of Glycolytic Metabolites and Their Regulating Proteins in Myocardium from Human Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 26(9). 1941–1951. 10 indexed citations
6.
Koleini, Navid, Aleksandra Binek, Mohammad Keykhaei, et al.. (2024). Myocardial ultrastructure of human heart failure with preserved ejection fraction. Nature Cardiovascular Research. 3(8). 907–914. 15 indexed citations
7.
Patel, Chirag H., Yi Dong, Navid Koleini, et al.. (2023). TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy. JCI Insight. 8(21). 8 indexed citations
8.
Koleini, Navid, Barbara E. Nickel, Raghu S. Nagalingam, et al.. (2021). Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression. Cell and Tissue Research. 385(3). 753–768. 6 indexed citations
9.
Landry, Natalie M., Sunil G. Rattan, Thomas Meier, et al.. (2021). SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation. Basic Research in Cardiology. 116(1). 25–25. 26 indexed citations
10.
Koleini, Navid, et al.. (2021). Cardiovascular complications of COVID-19. JCI Insight. 6(13). 89 indexed citations
11.
Shojaei, Shahla, Navid Koleini, Ehsan Samiei, et al.. (2019). Simvastatin increases temozolomide‐induced cell death by targeting the fusion of autophagosomes and lysosomes. FEBS Journal. 287(5). 1005–1034. 94 indexed citations
12.
Koleini, Navid, Barbara E. Nickel, Andrea L. Edel, et al.. (2019). Oxidized phospholipids in Doxorubicin-induced cardiotoxicity. Chemico-Biological Interactions. 303. 35–39. 97 indexed citations
13.
Koleini, Navid, Barbara E. Nickel, Andrea L. Edel, et al.. (2018). Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway. Cell and Tissue Research. 374(3). 607–617. 9 indexed citations
14.
Koleini, Navid, Jon‐Jon Santiago, Barbara E. Nickel, et al.. (2018). Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity. American Journal of Physiology-Heart and Circulatory Physiology. 316(2). H279–H288. 11 indexed citations
15.
Shojaei, Shahla, Javad Alizadeh, James A. Thliveris, et al.. (2018). Inhibition of Autophagy by Mevalonate Pathway Inhibitors, a New Therapeutic Approach to sensitize Glioblastoma Cells to Temozolomide Induced Apoptosis. The FASEB Journal. 32(S1). 5 indexed citations
16.
Koleini, Navid & Elissavet Kardami. (2017). Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity. Oncotarget. 8(28). 46663–46680. 237 indexed citations
17.
Koleini, Navid, Barbara E. Nickel, Jie Wang, et al.. (2017). Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathway. Oncotarget. 8(50). 87415–87430. 25 indexed citations
18.
Santiago, Jon‐Jon, Navid Koleini, Xin Ma, et al.. (2014). High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling. PLoS ONE. 9(5). e97281–e97281. 52 indexed citations
19.
Tehrani, Hatav Ghasemi, et al.. (2010). Effects of Letrozole Compared with Danazol on Patients with Confirmed Endometriosis: A Randomized Clinical Trial. SHILAP Revista de lepidopterología. 16 indexed citations
20.
Hashemipour, Mahin, Ammar Hassanzadeh Keshteli, Mansour Siavash, et al.. (2009). Vitamin A status does not contribute to the residual goiter in schoolchildren of Isfahan, an iodine replenished area. International Journal of Food Sciences and Nutrition. 60(sup5). 19–27. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026